Sale!

CEBPA Full Gene Mutation Analysis Test Cost

Original price was: 2,400 د.إ.Current price is: 1,800 د.إ.

-25%

The CEBPA Full Gene Mutation Analysis Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the CEBPA gene. This gene plays a critical role in the development and function of certain types of white blood cells, and mutations in CEBPA are associated with an increased risk of developing acute myeloid leukemia (AML), a type of cancer that affects the blood and bone marrow.

The test involves a detailed examination of the CEBPA gene to detect any abnormalities or mutations. It is particularly useful for patients who have been diagnosed with AML, as the presence of CEBPA mutations can influence treatment decisions and prognosis. The test can also be used for individuals with a family history of AML or related blood disorders, as part of a comprehensive genetic assessment.

Performed at the state-of-the-art facilities of DNA Labs UAE, the CEBPA Full Gene Mutation Analysis Test is conducted by a team of experienced geneticists and laboratory technicians. The cost of the test is 1800 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the CEBPA gene.

For patients and families facing the challenges of AML, this test offers valuable insights into the genetic factors influencing the disease, enabling more personalized and effective treatment strategies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

None

Test Name CEBPA Full Gene Mutation Analysis Test
Components EDTA Vacutainer (2ml)
Price 1800.0 AED
Sample Condition Peripheral Blood
Report Delivery 5-6 days
Method Sanger Sequencing
Test type Genetics
Doctor Gynecologist
Test Department:
Pre Test Information CEBPA Full Gene Mutation Analysis can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

CEBPA full gene mutation analysis is a genetic test that examines the entire CEBPA gene for mutations or changes in the DNA sequence. CEBPA (CCAAT/enhancer binding protein alpha) is a transcription factor that plays a critical role in the regulation of cell growth and differentiation, particularly in the development of myeloid cells.

Mutations in the CEBPA gene have been associated with various disorders, including acute myeloid leukemia (AML) and familial acute myeloid leukemia. The CEBPA full gene mutation analysis can help identify specific mutations within the gene that may be contributing to the development of these disorders.

The analysis is typically performed using a DNA sample obtained from blood or bone marrow. The DNA is extracted and sequenced to determine the exact sequence of the CEBPA gene. Any mutations or changes in the DNA sequence are identified and reported.

The results of the CEBPA full gene mutation analysis can provide valuable information for diagnosis, prognosis, and treatment planning in individuals with suspected or confirmed AML or other related disorders. It can help guide personalized treatment strategies and provide insight into the genetic basis of the disease.

It is important to note that this test specifically focuses on mutations within the CEBPA gene and does not provide information on mutations in other genes that may also be relevant to the development of AML or related disorders. Therefore, it is often performed in conjunction with other genetic tests to obtain a comprehensive genetic profile of the individual.